Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-25-033825
Filing Date
2025-04-10
Accepted
2025-04-10 17:28:56
Documents
2
Period of Report
2025-04-10

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2512020d2_6k.htm 6-K 9646
2 EXHIBIT 99.1 tm2512020d2_ex99-1.htm EX-99.1 157641
  Complete submission text file 0001104659-25-033825.txt   168275
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 25829331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)